3-(4-METHOXYPHENYL)-N-(2-MORPHOLINOPYRIMIDIN-4-YL)ISOXAZOL-5-AMINE, 95%, 100mg

1-(4-Pyridyl)piperazine, 98.0%, 1g

5-Iodo-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 5g

Methyl 3,3-dimethyloxetane-2-carboxylate, 98%, 250mg

1,3-Cyclohexanedione, 99.00%, 1g

Magnetic stirring bars ROTILABO® glass-coated, , 6 mm, 25 mm, 10 pieces

2,2-Bis (4-aminophenyl)hexafluoropropane, 95.0%, 100g

Toluene, min. 99.5%, for synthesis, 2.5 L, glass packaging

(2S,5R,6R)-6-((S)-2-Amino-2-(4-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (Amoxicillin Impurity), 97%, 25mg

2,5-di([1,1'-Biphenyl]-4-yl)-1,3,4-oxadiazole, 98%, 5g

(2R,3S)-3-Phenylisoserine hydrochloride, 95.0%, 1g

Fmoc-D-Tic-OH, 95.0%, 5g

2,3-Difluoro-4-hydroxybenzaldehyde, 98.0%, 1g